(Q74587640)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600710%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

The expression of complement regulatory proteins by adult human oligodendrocytes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600710%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600710%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

N J Scolding

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600710%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

D A Compston

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600710%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 April 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600710%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuroimmunology

11 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600710%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

84

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600710%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

69-75

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600710%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600710%20AND%20SRC:MED&resulttype=core&format=json

Pre-oligodendrocytes from adult human CNS

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900241-5

7 January 2021

Complement biosynthesis in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900241-5

7 January 2021

Activation of the complement cascade and increase of clusterin in the brain following a cortical contusion in the adult rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900241-5

7 January 2021

Growth of a rat neuroblastoma cell line in serum-free supplemented medium

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900241-5

7 January 2021

Immunocytochemical localization of the terminal complement complex in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900241-5

7 January 2021

Complement regulatory protein expression by a human oligodendrocyte cell line: cytokine regulation and comparison with astrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900241-5

7 January 2021

Upregulation of human neutrophil CD59, a regulator of the membrane attack complex of complement, following cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900241-5

7 January 2021

Myelinated nerve fibres in the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900241-5

7 January 2021

Complement regulatory molecules on human myelin and glial cells: differential expression affects the deposition of activated complement proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900241-5

7 January 2021

Complement activation in the central nervous system following blood-brain barrier damage in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900241-5

7 January 2021

Perforin: structure and function

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900241-5

7 January 2021

Sulfated glycoprotein 2: new relationships of this multifunctional protein to neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900241-5

7 January 2021

The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900241-5

7 January 2021

Physiology and pathophysiology of complement: progress and trends.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900241-5

7 January 2021

Membrane proteins that protect against complement lysis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900241-5

7 January 2021

Expression of complement in the brain: role in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900241-5

7 January 2021

Clusterin (SGP-2): a multifunctional glycoprotein with regional expression in astrocytes and neurons of the adult rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900241-5

7 January 2021

Killing of rat glial cells by complement: deficiency of the rat analogue of CD59 is the cause of oligodendrocyte susceptibility to lysis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900241-5

7 January 2021

Cerebrospinal fluid concentrations of the complement MAC inhibitor CD59 in multiple sclerosis and patients with other neurological disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900241-5

7 January 2021

Expression and function of membrane regulators of complement on rat astrocytes in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900241-5

7 January 2021

Clusterin: physiologic and pathophysiologic considerations.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900241-5

7 January 2021

Serum cytotoxicity to human and rat oligodendrocytes in culture.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900241-5

7 January 2021

Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900241-5

7 January 2021

Normal rat serum cytotoxicity against syngeneic oligodendrocytes. Complement activation and attack in the absence of anti-myelin antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900241-5

7 January 2021

The pathogenesis of demyelinating disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900241-5

7 January 2021

A proliferative adult human oligodendrocyte progenitor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900241-5

7 January 2021

Release of leukotriene B4 from sublethally injured oligodendrocytes by terminal complement complexes.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900241-5

7 January 2021

Role of complement in the aetiology of Pick's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900241-5

7 January 2021

Mechanisms of oligodendrocyte interaction with normal human serum - defining the role of complement

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900241-5

7 January 2021

10.1016/S0165-5728(97)00241-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600710%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference